Talphera, Inc. (TLPH) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Talphera reported revenue of $28,000. Net income was -$14.3M (a -51035.7% net margin). Operating margin was -48157.1%. Operating activities generated -$11.4M of cash. At fiscal year end, Talphera held $29.7M in total assets against $12.7M in total liabilities, including $5.9M of cash and equivalents.
Open the full interactive Talphera financials → Quarterly statements, key ratios, valuation history and price charts.
Talphera Key Stats
| Share Price | $1.07 |
|---|---|
| Market Cap | $80.8M |
| 52-Week Range | $0.72 – $1.47 |
| Shares Outstanding | 75.5 million (basic, 2026 Q2) |
Talphera Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $5.4M | $2.8M | $1.8M | $651,000 | $0 | $28,000 |
| Cost of Goods Sold | $6.0M | $3.8M | $2.6M | — | — | — |
| Gross Profit | -$616,000 | -$935,000 | -$820,000 | — | — | — |
| Operating Income | -$41.0M | -$36.0M | -$36.6M | -$16.9M | -$15.3M | -$13.5M |
| Pre-Tax Income | -$40.4M | -$35.1M | $47.8M | -$10.3M | -$13.0M | -$14.3M |
| Income Tax | $4,000 | $5,000 | $13,000 | $0 | $0 | $0 |
| Net Income | -$40.4M | -$35.1M | $47.8M | -$18.4M | -$13.0M | -$14.3M |
| Diluted EPS | -$9.40 | -$5.80 | $5.72 | -$1.29 | — | — |
Talphera Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1,000 | $0 | $0 | $0 |
| Net Income | -$4.4M | -$3.8M | -$2.6M | -$4.3M |
Talphera Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $27.3M | $12.7M | $15.3M | $5.7M | $8.9M | $5.9M |
| Current Assets | $46.8M | $55.5M | $24.6M | $11.6M | $9.4M | $20.9M |
| Total Assets | $66.3M | $77.9M | $47.5M | $20.4M | $18.2M | $29.7M |
| Current Liabilities | $17.6M | $18.5M | $13.8M | $4.5M | $2.6M | $3.8M |
| Total Long-Term Debt | $21.9M | $13.8M | $11.5M | — | — | — |
| Total Liabilities | $122.0M | $113.8M | $25.7M | $6.3M | $10.2M | $12.7M |
| Shareholders' Equity | -$55.8M | -$35.9M | $21.8M | $14.1M | $8.0M | $17.0M |
Talphera Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$38.5M | -$30.0M | -$28.3M | -$17.5M | -$12.7M | -$11.4M |
| Cash From Investing | $34.1M | -$26.1M | $36.5M | -$528,000 | $3.8M | -$14.3M |
| Cash From Financing | $17.0M | $41.5M | -$507,000 | $3.5M | $12.0M | $22.7M |
| Free Cash Flow | -$40.4M | -$31.8M | -$28.7M | -$17.6M | -$12.7M | — |
Figures from Talphera's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Talphera financials page for every line item.
Talphera Company Profile
| Ticker | TLPH |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | San Mateo, California |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001427925 |
Frequently Asked Questions
What was Talphera's revenue in fiscal 2025?
Talphera (TLPH) reported revenue of $28,000 for fiscal 2025.
What is Talphera's annual revenue history?
Talphera's annual revenue by fiscal year: 2020: $5.4M; 2021: $2.8M; 2022: $1.8M; 2023: $651,000; 2024: $0; 2025: $28,000.
What was Talphera's net income in fiscal 2025?
Talphera reported net income of -$14.3M for fiscal 2025.
What was Talphera's revenue last quarter?
In its most recent reported quarter (2026 Q2), Talphera reported revenue of $0.
How many shares of Talphera are outstanding?
Talphera reported a weighted average of 75.5 million basic shares outstanding in 2026 Q2.
What is Talphera's market cap?
Based on its latest closing price, Talphera (TLPH) has a market capitalization of about $80.8M.
When does Talphera's fiscal year end?
Talphera's fiscal year end, as registered with the SEC, is December 31.
Where is Talphera headquartered?
Talphera lists its business address in San Mateo, California in its SEC filings.